Jump to main content
Jump to site search

Issue 45, 2008
Previous Article Next Article

Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease

Author affiliations

Abstract

Selective design modifications of specifically substituted 3-hydroxy-4(1H)-pyridinones show possibly advantageous ring freedom while maintaining metal-binding ability and antioxidant capacity, moving toward an efficient potential treatment for Alzheimer's disease.

Graphical abstract: Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease

Back to tab navigation

Supplementary files

Publication details

The article was received on 03 Sep 2008, accepted on 12 Sep 2008 and first published on 06 Oct 2008


Article type: Communication
DOI: 10.1039/B815404J
Citation: Dalton Trans., 2008,0, 6364-6367
  •   Request permissions

    Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease

    L. E. Scott, B. D. G. Page, B. O. Patrick and C. Orvig, Dalton Trans., 2008, 0, 6364
    DOI: 10.1039/B815404J

Search articles by author

Spotlight

Advertisements